COVID-19 drugmaker switches CEOs for second time in 5 days

One of the local biotechs developing a vaccine for COVID-19 has announced its second chief executive change in the last week, amid rumors that President Donald Trump attempted to negotiate exclusive rights to the company’s drug.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.